中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2013年
3期
286-289
,共4页
于长华%朱卫国%吉雅玲%郭佳妮%潘鹏%韩济华%周锡垒%李涛%张艳
于長華%硃衛國%吉雅玲%郭佳妮%潘鵬%韓濟華%週錫壘%李濤%張豔
우장화%주위국%길아령%곽가니%반붕%한제화%주석루%리도%장염
子宫颈癌%调强放疗%毒性反应%临床疗效
子宮頸癌%調彊放療%毒性反應%臨床療效
자궁경암%조강방료%독성반응%림상료효
Cervical cancer%Intensity-modulated radiotherapy%Toxicity%Clinical efficacy
目的 比较强调的两种放疗方式并同步化疗治疗局部进展期宫颈癌,评价其治疗反应情况和疗效.方法 符合入组条件的Ⅱa~Ⅲb期宫颈癌患者采用信封法随机分组,研究组制定IMRT放疗计划,对宫颈原发病灶予以45 Gy/22次,盆壁淋巴引流区50 Gy/22次;对照组靶区设定标准同研究组,采用四野盒式照射45 Gy/22次,其后予以盆壁补充6 Gy/3次.两组患者同期化疗方案相同,给予奈达铂30 mg/m2,每周1次,共6周期化疗.后装治疗于外照射3~4周开始,每次6 Gy,共6次,A点总剂量36Gy.结果 自2006年9月至2009年9月,共招募72例患者,其中研究组36例,对照组36例.两组在恶心呕吐、血红蛋白下降、中性粒细胞下降等差异均无统计学意义;研究组Ⅲ级腹泻发生率为5.6%;对照组Ⅲ级腹泻发生率为30.6%,两组Ⅲ~Ⅳ级腹泻发生率比较差异有统计学意义(x2=31.35,P<0.05).1、2、3年生存率分别为94.4%、86.1%、77.8%,1、2、3年无瘤生存率分别为91.7%、75.0%、72.2%,对照组1、2、3年生存率分别为91.7%、86.1%、75.0%,1、2、3年无瘤生存率分别为91.7%、72.2%、69.4%,差异无统计学意义.结论 宫颈癌调强放疗并同步化疗可以明显减少急性直肠炎的发生率,总生存率与无病生存率与四野盒式照射相似.
目的 比較彊調的兩種放療方式併同步化療治療跼部進展期宮頸癌,評價其治療反應情況和療效.方法 符閤入組條件的Ⅱa~Ⅲb期宮頸癌患者採用信封法隨機分組,研究組製定IMRT放療計劃,對宮頸原髮病竈予以45 Gy/22次,盆壁淋巴引流區50 Gy/22次;對照組靶區設定標準同研究組,採用四野盒式照射45 Gy/22次,其後予以盆壁補充6 Gy/3次.兩組患者同期化療方案相同,給予奈達鉑30 mg/m2,每週1次,共6週期化療.後裝治療于外照射3~4週開始,每次6 Gy,共6次,A點總劑量36Gy.結果 自2006年9月至2009年9月,共招募72例患者,其中研究組36例,對照組36例.兩組在噁心嘔吐、血紅蛋白下降、中性粒細胞下降等差異均無統計學意義;研究組Ⅲ級腹瀉髮生率為5.6%;對照組Ⅲ級腹瀉髮生率為30.6%,兩組Ⅲ~Ⅳ級腹瀉髮生率比較差異有統計學意義(x2=31.35,P<0.05).1、2、3年生存率分彆為94.4%、86.1%、77.8%,1、2、3年無瘤生存率分彆為91.7%、75.0%、72.2%,對照組1、2、3年生存率分彆為91.7%、86.1%、75.0%,1、2、3年無瘤生存率分彆為91.7%、72.2%、69.4%,差異無統計學意義.結論 宮頸癌調彊放療併同步化療可以明顯減少急性直腸炎的髮生率,總生存率與無病生存率與四野盒式照射相似.
목적 비교강조적량충방료방식병동보화료치료국부진전기궁경암,평개기치료반응정황화료효.방법 부합입조조건적Ⅱa~Ⅲb기궁경암환자채용신봉법수궤분조,연구조제정IMRT방료계화,대궁경원발병조여이45 Gy/22차,분벽림파인류구50 Gy/22차;대조조파구설정표준동연구조,채용사야합식조사45 Gy/22차,기후여이분벽보충6 Gy/3차.량조환자동기화료방안상동,급여내체박30 mg/m2,매주1차,공6주기화료.후장치료우외조사3~4주개시,매차6 Gy,공6차,A점총제량36Gy.결과 자2006년9월지2009년9월,공초모72례환자,기중연구조36례,대조조36례.량조재악심구토、혈홍단백하강、중성립세포하강등차이균무통계학의의;연구조Ⅲ급복사발생솔위5.6%;대조조Ⅲ급복사발생솔위30.6%,량조Ⅲ~Ⅳ급복사발생솔비교차이유통계학의의(x2=31.35,P<0.05).1、2、3년생존솔분별위94.4%、86.1%、77.8%,1、2、3년무류생존솔분별위91.7%、75.0%、72.2%,대조조1、2、3년생존솔분별위91.7%、86.1%、75.0%,1、2、3년무류생존솔분별위91.7%、72.2%、69.4%,차이무통계학의의.결론 궁경암조강방료병동보화료가이명현감소급성직장염적발생솔,총생존솔여무병생존솔여사야합식조사상사.
Objective To study two different methods of radiotherapy and their side-effects in treating local advanced cervical cancer.Methods Eligible patients with stage Ⅱ a ~ Ⅲb cervical cancer were randomly divided into the study group and the control group.The patients in the study group were irradiated to 45 Gy/22 fractions at primary lesions and 50 Gy/22 fractions at lymphatic drainage using IMRT followed by high-dose rate (HDR) brachytherapy (36 Gy/6 fractions).The control group had the same target range sizes as the study group,and the patients were irradiated to 45 Gy/22 fractions at pelvic cavity and additional 6 Gy/3 fractions at pelvic wall using four-field cassette technique followed by highdose rate (HDR) brachytherapy (36/6 fractions).Both groups were treated with concurrent chemotherapy,by nedaplatin 30 mg/m2 weekly for a total of 6 cycles.Results Between Sep 2006 and Sep 2009,72 patients were enrolled into the study,and 36 cases were assigned in the study group and 36 cases in the control group.Nausea and vomiting,decline of hemoglobin and neutrophil were similar in two groups.Grade Ⅲ diarrhea in the study group and the control group was 5.6% and 30.6%,respectively,with significant difference in diarrhea.1-,2-and 3-year overall survival rates of the study group were 94.4%,86.1%,77.8%,and 1-,2-and 3-year disease-free survival rate were 91.7%,75.0%,72.2% in the study group.and 1-,2-and 3-year overall survival rate were 91.7%,86.1%,75.0%,and 1-,2-and 3-year disease-free survival rate were 91.7%,72.2%,69.4% in the control group,respectively.There were no significant differences for overall survival and disease-free survival between two groups.Conclusions Intensity modulated radiation therapy with cervical cancer can reduce significantly the rate of acute proctitis.Overall survival and disease-free survival might be similar in two groups.